- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT04043624
The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic
Обзор исследования
Подробное описание
The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.
Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.
Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .
Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.
Тип исследования
Регистрация (Ожидаемый)
Фаза
- Фаза 4
Контакты и местонахождение
Места учебы
-
-
Zhejiang
-
Hangzhou, Zhejiang, Китай, 310009
- Рекрутинг
- The Second Affiliated Hospital Zhejiang University School of Medicine
-
Контакт:
- Jin Ma
- Номер телефона: 86+18867539602
- Электронная почта: 1241370980@qq.com
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
- Age ≧ 18 years old, ≦70 years old
- Temperature, white blood cells, and hemoglobin were normal before surgery
- Patient informed consent
Exclusion Criteria:
- Patients with a history of surgery within six months
- Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
- American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
- Allergic to lidocaine
- Bradycardia (heart rate < 60 beats/min) or atrioventricular block
- Mental disorder
- Patients requiring a right double lumen bronchial catheter
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
|
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
|
|
Плацебо Компаратор: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
|
IV bolus of saline, followed by continuous infusion of saline
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Postoperative pain score
Временное ограничение: Immediately postoperation
|
Using Visual Analogue Scales
|
Immediately postoperation
|
|
Postoperative pain score
Временное ограничение: 1 hour postoperation
|
Using Visual Analogue Scales
|
1 hour postoperation
|
|
Postoperative pain score
Временное ограничение: 4 hours postoperation
|
Using Visual Analogue Scales
|
4 hours postoperation
|
|
Postoperative pain score
Временное ограничение: 8 hours postoperation
|
Using Visual Analogue Scales
|
8 hours postoperation
|
|
Postoperative pain score
Временное ограничение: 24 hours postoperation
|
Using Visual Analogue Scales
|
24 hours postoperation
|
|
Postoperative pain score
Временное ограничение: 48 hours postoperation
|
Using Visual Analogue Scales
|
48 hours postoperation
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Opioid requirement
Временное ограничение: Immediately postoperation
|
The dosage of opioids was recorded
|
Immediately postoperation
|
|
Opioid requirement
Временное ограничение: 1 hour postoperation
|
The dosage of opioids was recorded
|
1 hour postoperation
|
|
Opioid requirement
Временное ограничение: 4 hours postoperation
|
The dosage of opioids was recorded
|
4 hours postoperation
|
|
Opioid requirement
Временное ограничение: 8 hours postoperation
|
The dosage of opioids was recorded
|
8 hours postoperation
|
|
Opioid requirement
Временное ограничение: 24 hours postoperation
|
The dosage of opioids was recorded
|
24 hours postoperation
|
|
Opioid requirement
Временное ограничение: 48 hours postoperation
|
The dosage of opioids was recorded
|
48 hours postoperation
|
|
Pressing times of PCIA postoperation
Временное ограничение: 48 hours postoperation
|
The pressing times of PCIA within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Occurrence of nausea and/or vomiting
Временное ограничение: 48 hours postoperation
|
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Blood level of adrenaline
Временное ограничение: before induction
|
Perioperative blood level of adrenaline was recorded
|
before induction
|
|
Blood level of adrenaline
Временное ограничение: after incision
|
Perioperative blood level of adrenaline was recorded
|
after incision
|
|
Blood level of adrenaline
Временное ограничение: immediately after extubation
|
Perioperative blood level of adrenaline was recorded
|
immediately after extubation
|
|
Blood level of norepinephrine
Временное ограничение: before induction
|
Perioperative blood level of norepinephrine was recorded
|
before induction
|
|
Blood level of norepinephrine
Временное ограничение: after incision
|
Perioperative blood level of norepinephrine was recorded
|
after incision
|
|
Blood level of norepinephrine
Временное ограничение: immediately after extubation
|
Perioperative blood level of norepinephrine was recorded
|
immediately after extubation
|
|
Blood level of adrenocortical
Временное ограничение: before induction
|
Perioperative blood level of adrenocortical was recorded
|
before induction
|
|
Blood level of adrenocortical
Временное ограничение: after incision
|
Perioperative blood level of adrenocortical was recorded
|
after incision
|
|
Blood level of adrenocortical
Временное ограничение: immediately after extubation
|
Perioperative blood level of adrenocortical was recorded
|
immediately after extubation
|
|
Blood level of TNF-alpha
Временное ограничение: before induction
|
Perioperative blood level of TNF-alpha was recorded
|
before induction
|
|
Blood level of TNF-alpha
Временное ограничение: after incision
|
Perioperative blood level of TNF-alpha was recorded
|
after incision
|
|
Blood level of TNF-alpha
Временное ограничение: immediately after extubation
|
Perioperative blood level of TNF-alpha was recorded
|
immediately after extubation
|
|
Blood level of IL-6
Временное ограничение: before induction
|
Perioperative blood level of IL-6 was recorded
|
before induction
|
|
Blood level of IL-6
Временное ограничение: after incision
|
Perioperative blood level of IL-6 was recorded
|
after incision
|
|
Blood level of IL-6
Временное ограничение: immediately after extubation
|
Perioperative blood level of IL-6 was recorded
|
immediately after extubation
|
|
Blood level of IL-10
Временное ограничение: before induction
|
Perioperative blood level of IL-10 was recorded
|
before induction
|
|
Blood level of IL-10
Временное ограничение: after incision
|
Perioperative blood level of IL-10 was recorded
|
after incision
|
|
Blood level of IL-10
Временное ограничение: immediately after extubation
|
Perioperative blood level of IL-10 was recorded
|
immediately after extubation
|
|
Duration of hospital stay
Временное ограничение: from day of surgery until day of discharge from hospital
|
length of hospital stay (in days)
|
from day of surgery until day of discharge from hospital
|
Соавторы и исследователи
Следователи
- Учебный стул: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University
Публикации и полезные ссылки
Общие публикации
- Lauwick S, Kim DJ, Michelagnoli G, Mistraletti G, Feldman L, Fried G, Carli F. Intraoperative infusion of lidocaine reduces postoperative fentanyl requirements in patients undergoing laparoscopic cholecystectomy. Can J Anaesth. 2008 Nov;55(11):754-60. doi: 10.1007/BF03016348.
- Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6. doi: 10.1097/00000542-200701000-00007.
- Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004 Apr;98(4):1050-1055. doi: 10.1213/01.ANE.0000104582.71710.EE.
- Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov;109(5):1464-9. doi: 10.1213/ANE.0b013e3181bab1bd.
- Schafranski MD, Malucelli T, Machado F, Takeshi H, Kaiber F, Schmidt C, Harth F. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol. 2009 Jul;28(7):853-5. doi: 10.1007/s10067-009-1137-8. Epub 2009 Mar 5.
- Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003345. doi: 10.1002/14651858.CD003345.pub2.
- Buchanan DD, J MacIvor F. A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life. Support Care Cancer. 2010 Jul;18(7):899-901. doi: 10.1007/s00520-010-0864-3. Epub 2010 Apr 29.
- Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage. 2009 Jan;37(1):85-93. doi: 10.1016/j.jpainsymman.2007.12.023. Epub 2008 Jul 2.
- Eriksson AS, Sinclair R, Cassuto J, Thomsen P. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology. 1992 Jul;77(1):74-8. doi: 10.1097/00000542-199207000-00011.
- Feng G, Liu S, Wang GL, Liu GJ. Lidocaine attenuates lipopolysaccharide-induced acute lung injury through inhibiting NF-kappaB activation. Pharmacology. 2008;81(1):32-40. doi: 10.1159/000107792. Epub 2007 Sep 4.
Даты записи исследования
Изучение основных дат
Начало исследования (Ожидаемый)
Первичное завершение (Ожидаемый)
Завершение исследования (Ожидаемый)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
- Физиологические эффекты лекарств
- Молекулярные механизмы фармакологического действия
- Антиаритмические агенты
- Депрессанты центральной нервной системы
- Агенты периферической нервной системы
- Агенты сенсорной системы
- Анестетики
- Модуляторы мембранного транспорта
- Анестетики местные
- Блокаторы потенциалзависимых натриевых каналов
- Блокаторы натриевых каналов
- Лидокаин
Другие идентификационные номера исследования
- 2019-084
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .